![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No Pharmacokinetic Interaction Between the Hepatitis C Virus Non-Structural Protein 5A Inhibitor MK-8742 and Ethinyl Estradiol and Levonorgestrel
|
|
|
Reported by Jules Levin
HEP DART Dec 8-12 2013
Biennial Frontiers in Drug Development for Viral Hepatitis
The Big Island, Hawaii
WL Marshall1, WW Yeh1, L Caro1, S Langley1, J Ma1, E Mangin1, X Huang1, R Valesky1, TE O'Reilly2, and JR Butterton1
1Merck, Whitehouse Station NJ, USA; 2Celerion, Phoenix, AZ, USA
![AASLD1.gif](../images/121613/121613-4/AASLD1.gif)
![AASLD2.gif](../images/121613/121613-4/AASLD2.gif)
![AASLD3.gif](../images/121613/121613-4/AASLD3.gif)
![AASLD4.gif](../images/121613/121613-4/AASLD4.gif)
![AASLD5.gif](../images/121613/121613-4/AASLD5.gif)
![AASLD6.gif](../images/121613/121613-4/AASLD6.gif)
![AASLD7.gif](../images/121613/121613-4/AASLD7.gif)
![AASLD8.gif](../images/121613/121613-4/AASLD8.gif)
![AASLD9.gif](../images/121613/121613-4/AASLD9.gif)
![AASLD10.gif](../images/121613/121613-4/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|